Table 2.
Isolate | AMR Phenotype* |
---|---|
E. casseliflavus B72 | ERYI, Q-DR |
E. casseliflavus B79 | VANI, ERYI, Q-DI |
E. faecalis W460 | ERYI, Q-DR |
E. faecalis W350 | DOXR, ERYI, LZDI |
E. faecalis W191 | DOXR, Q-DR |
E. faecalis H120S2 | ERYR, STRI |
E. faecalis H114S2 | VANR, TECR, AMPR, LVXR |
E. faecalis C34 | VANR, TECR, ERYI, LZDI, Q-DR |
E. faecalis C33 | TECR, DOXR, ERYR, LZDI,LVXR, Q-DR |
E. faecalis B168 | DOXI, ERYI, LZDI, Q-DR |
E. faecalis B150 | TECR, DOXI, ERYR, LZDR, Q-DR |
E. faecalis B6 | DOXR, ERYI, Q-DR |
E. faecalis B48 | DOXR, ERYR, LZDR, Q-DR |
E. faecalis B139 | VANI, LZDI, Q-DR |
E. faecalis C106 | TECR, DOXR, ERYR, GENR, Q-DR |
E. faecalis C379 | DOXR, ERYI, Q-DR |
E. faecalis R61 | VANI, TECR, DOXR, ERYR, GENI, LZDI, Q-DR |
E. faecalis R76 | DOXR, ERYR, GENR, Q-DR, STRR |
E. faecalis R95 | DOXI, ERYR, GENI, LZDI, Q-DR, STRR |
E. faecalis R378 | ERYI, Q-DI |
E. faecalis R395 | VANI, TECR, DOXR, ERYI, Q-DR |
E. faecalis W37 | DOXI, ERYR, LVXR, Q-DI, STRR |
E. faecalis W41 | VANI, TECR, DOXR, ERYI, Q-DR |
E. faecalis W75 | VANI, Q-DI |
E. faecalis W195 | DOXI, ERYI, Q-DR |
E. faecalis W314 | TECR, ERYI, LZDR, Q-DR |
E. faecium R407 | VANR, TECR, AMPR, ERYR, GENR, LVXR, STRR |
E. faecium R337 | VANR, TECR, AMPR, ERYR, NITI, LVXR, STRR |
E. faecium H53S1 | VANR, TECR, AMPR, ERYR, LVXR, STRI |
E. faecium F11 J | VANR, TECR, AMPR, ERYR, LVXR, STRR |
E. faecium C329 | TECR, ERYI, NITR, LZDI, LVXR |
E. faecium B492 | VANR, TECR, AMPR, ERYR, LVXR, STRR |
E. faecium B466 | AMPR, DOXR, ERYR, NITI, LVXI |
E. faecium C12D | VANR, TECR, AMPR, ERYI, LVXR |
E. faecium C567 | ERYR, NITI, LZDI |
E. faecium H101S2 | VANR, TECR, AMPR, ERYR, LVXR, STRI |
E. faecium H123S2 | VANR, TECR, AMPR, ERYR, LVXR, STRI |
E. gallinarum W17 | VANI |
E. gallinarum G12S | VANI |
a AMR phenotypic profiles using R for resistant to the antimicrobial and I for intermediately resistant to the antimicrobial. Antimicrobials used for disc susceptibility testing were vancomycin (VAN), teicoplanin (TEC), amipicillin (AMP), doxycycline (DOX), erythromycin (ERY), levofloxacin (LVX), linezolid (LZD), nitrofurantoin (NIT), gentamicin (GEN), streptomycin (STR), quinupristin/dalfopristin (Q-D), and tigecycline (TGC)